Observational studyThe Lancet. Global health2018

Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study.

Rebecca Zash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.